Abstract
Reliable assessment of cell death is now pivotal to many research programs aiming at generating new antitumor compounds or at screening cDNA libraries to identify genes with pro - or antiapoptotic functions. Such approaches need to rely on reproducible, easy handling, and rapid microplate-based cytotoxicity assays that are amenable to high-throughput screening technologies. We describe here a method for the direct measurement of cell death, based on the detection of a decrease in fluorescence observed following death induction in cells stably expressing enhanced green fluorescent protein (EGFP). Our data clearly show that such a decrease in EGFP fluorescence after cell death induction happens in various cell types, including those routinely used in anticancer drug screening (i.e., murine and human, lymphoid, fibroblastic, or epithelial cell lines). Moreover, the decrease in EGFP fluorescence is observed in cells induced to die by a variety of apoptosis-inducing agents, such as glucocorticoids (dexamethasone), DNAdamaging agents (etoposide, cisplatin), microtubule disorganizers (paclitaxel), protein kinase C inhibitors (staurosporine), or a caspase-independent apoptotic stimulus (CD45 crosslinking). A decrease in fluorescence can be assessed either by flow cytometry or with a fluorescence microplate reader. The kinetics and specificity of this EGFP-based assay were comparable with those of other conventional techniques used to detect cell death. This novel EGFP-based microplate assay combines sensitivity and rapidity and is amenable to high-throughput setups, making it an assay of choice for evaluation of cell cytotoxicity.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Nieminen, A. L., Gores, G. J., Bond, J. M., Imberti, R., Herman, B., and Lemasters, J. J. (1992) A novel cytotoxicity screening assay using a multiwell fluorescence scanner. Toxicol. Appl. Pharmacol. 115, 147–155.
Rat, P., Korwin-Zmijowska, C., Warnet, J. M., and Adolphe, M. (1994) New in vitro fluorimetric microtitration assays for toxicological screening of drugs. Cell. Biol. Toxicol. 10, 329–337.
Weisenthal, L. M., Marsden, J. A., Dill, P. L., and Macaluso, C. K. (1983) A novel dye exclusion method for testing in vitro chemosensitivity of human tumors. Cancer Res. 43, 749–757.
Larsson, R., Nygren, P., Ekberg, M., and Slater, L. (1990) Chemotherapeutic drug sensitivity testing of human leukemia cells in vitro using a semiautomated fluorometric assay. Leukemia 4, 567–571.
Mosmann, T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55–63.
Pavlik, E. J., Flanigan, R. C., van Nagell, J. J., et al. (1985) Esterase activity, exclusion of propidium iodide, and proliferation in tumor cells exposed to anticancer agents: phenomena relevant to chemosensitivity determinations. Cancer Invest. 3, 413–426.
Scudiero, D. A., Shoemaker, R. H., Paull, K. D., Monks, A., Tierney, S., Nofziger, T. H., Currens, M. J., Seniff, D., and Boyd, M. R. (1988) Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 48, 4827–4833.
Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenney, S., and Boyd, M. R. (1990) New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. 82, 1107–1112.
Korzeniewski, C. and Callewaert, D. M. (1983) An enzyme-release assay for natural cytotoxicity. J. Immunol. Methods 64, 313–320.
Douglas, R. S., Tarshis, A. D., Pletcher, C. H. Jr., Nowell, P. C., and Moore, J. S. (1995) A simplified method for the coordinate examination of apoptosis and surface phenotype of murine lymphocytes. J. Immunol. Methods 188, 219–228.
Darzynkiewicz, Z., Bruno, S., Del Bino, G., et al. (1992) Features of apoptotic cells measured by flow cytometry. Cytometry 13, 795–808.
Dive, C., Gregory, C. D., Phipps, D. J., Evans, D. L., Milner, A. E., and Wyllie, A. H. (1992) Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry. Biochim. Biophys. Acta 1133, 275–285.
Gorczyca, W., Gong, J., and Darzynkiewicz, Z. (1993) Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res. 53, 1945–1951.
Kain, S. R. (1999) Green fluorescent protein (GFP): applications in cell-based assays for drug discovery. Drug Discov. Today 4, 304–312.
Hoffman, R. M. (1999) Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic. Invest. New Drugs 17, 343–359.
Tsien, R. Y. (1998) The green fluorescent protein. Annu. Rev. Biochem. 67, 509–544.
Blom, B., Heemskerk, M. H., Verschuren, M. C., et al. (1999) Disruption of alpha beta but not of gamma delta T cell development by overexpression of the helixloop-helix protein Id3 in committed T cell progenitors. EMBO J. 18, 2793–2802.
Yang, T. T., Cheng, L., and Kain, S. R. (1996) Optimized codon usage and chromophore mutations provide enhanced sensitivity with the green fluorescent protein. Nucleic Acids Res. 24, 4592, 4593.
Haskins, K., Kubo, R., White, J., Pigeon, M., Kappler, J., and Marrack, P. (1983) The major histocompatibility complex-restricted antigen receptor on T cells. I. Isolation with a monoclonal antibody. J. Exp. Med. 157, 1149–1169.
Martin, S. J., Reutelingsperger, C. P., McGahon, A. J., et al. (1995) Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J. Exp. Med. 182, 1545–1556.
Carter, W. O., Narayanan, P. K., and Robinson, J. P. (1994) Intracellular hydrogen peroxide and superoxide anion detection in endothelial cells. J. Leukoc. Biol. 55, 253–258.
Steff, A. M., Fortin, M., Arguin, C., and Hug, P. (2001) Detection of a decrease in green fluorescent protein fluorescence for the monitoring of cell death: an assay amenable to high-throughput screening technologies. Cytometry 45, 237–243.
Strebel, A., Harr, T., Bachmann, F., Wernli, M., and Erb, P. (2001) Green fluorescent protein as a novel tool to measure apoptosis and necrosis. Cytometry 43, 126–133.
Matsuyama, S., Llopis, J., Deveraux, Q. L., Tsien, R. Y., and Reed, J. C. (2000) Changes in intramitochondrial and cytosolic pH: early events that modulate caspase activation during apoptosis. Nat. Cell. Biol. 2, 318–325.
Barry, M. A. and Eastman, A. (1992) Endonuclease activation during apoptosis: the role of cytosolic Ca2+ and pH. Biochem. Biophys. Res. Commun. 186, 782–789.
Gottlieb, R. A., Nordberg, J., Skowronski, E., and Babior, B. M. (1996) Apoptosis induced in Jurkat cells by several agents is preceded by intracellular acidification. Proc. Natl. Acad. Sci. USA 93, 654–658.
Buttke, T. M. and Sandstrom, P. A. (1995) Redox regulation of programmed cell death in lymphocytes. Free Radic. Res. 22, 389–397.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Fortin, M., Steff, AM., Hugo, P. (2005). High-Throughput Technology. In: Blumenthal, R.D. (eds) Chemosensitivity. Methods in Molecular Medicine™, vol 110. Humana Press. https://doi.org/10.1385/1-59259-869-2:121
Download citation
DOI: https://doi.org/10.1385/1-59259-869-2:121
Publisher Name: Humana Press
Print ISBN: 978-1-58829-345-9
Online ISBN: 978-1-59259-869-4
eBook Packages: Springer Protocols